Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

NCT07205432 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Management in Adult Patients With Obesity or Overweight

Interventions

DRUG: XTL6001
DRUG: Placebo

Sponsor

Shanghai Xitaili Biomedicine Technology co., Ltd.